Pfizer director granted 7,686 phantom stock units

Buckley Mortimer J reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Buckley Mortimer J reported acquisition or exercise transactions in this Form 4 filing.

Pfizer Inc. director Mortimer J. Buckley received a grant of phantom stock units as part of his deferred compensation. On this Form 4, he was awarded 7,686.539 phantom stock units tied to Pfizer common stock, bringing his total phantom units to 24,391.124 held directly.

Each unit represents one phantom share of common stock and was granted under the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. These units reflect deferred director compensation and will be settled in cash or Pfizer common stock, at the director’s election, after he retires from the Board of Directors.

Insider Trade Summary

Grant/Award: 7,686.539 shares

Grant/Award 1 txn

Insider Buckley Mortimer J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock Units	7,686.539	$26.67	$205K

Holdings After Transaction: Phantom Stock Units — 24,391.124 contracts (Direct)

Footnotes (3)

1. F1. Each unit represents one phantom share of common stock.
2. F2. Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors.
3. F3. These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors.

Key Figures

Phantom stock units granted: 7,686.539 units Grant value reference price: $26.6700 per unit Total phantom units after grant: 24,391.124 units +2 more

5 metrics

Phantom stock units granted 7,686.539 units Award on 2026-04-23 to Mortimer J. Buckley

Grant value reference price $26.6700 per unit Price per phantom stock unit used in the award

Total phantom units after grant 24,391.124 units Holdings following the reported transaction

Underlying common stock 7,686.539 shares Common stock equivalent referenced by the units

Conversion or exercise price $0.0000 Phantom units under deferred compensation plan

Key Terms

Phantom Stock Units, Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors, deferred director's compensation

3 terms

Phantom Stock Units financial

"Each unit represents one phantom share of common stock."

Phantom stock units are company promises that pay a cash or stock-equivalent award tied to the firm’s share price or value growth, but they do not issue actual shares. Think of them as a bonus check that moves with the stock like a mirror rather than handing over an ownership slice. Investors care because these awards can affect a company’s future cash obligations, executive incentives and reported expenses without causing share dilution.

Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors financial

"Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors."

deferred director's compensation financial

"These units represent deferred director's compensation that are settled in cash or common stock"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Pfizer (PFE) director Mortimer J. Buckley report on this Form 4?

He reported an award of 7,686.539 phantom stock units linked to Pfizer common stock. These units are part of his deferred compensation and increase his total phantom unit holdings to 24,391.124, all held in a direct ownership capacity.

What are the phantom stock units awarded to the Pfizer (PFE) director?

The phantom stock units each represent one phantom share of Pfizer common stock. They track the value of the stock but are part of a deferred compensation arrangement and will be settled later in cash or common stock, rather than being current tradable shares.

Under which plan were the Pfizer (PFE) phantom stock units granted?

The units were granted under the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. This plan provides equity-linked awards as part of director compensation, allowing non-employee directors to receive value tied to Pfizer’s common stock.

When will the Pfizer (PFE) director receive value from these phantom stock units?

The phantom stock units represent deferred director compensation and are settled after the director retires from the Board. At that time, Mortimer J. Buckley can elect to receive settlement in either cash or Pfizer common stock according to the plan’s terms.

Does this Pfizer (PFE) Form 4 show an open-market stock purchase or sale?

No, it reports a grant of phantom stock units as compensation, not an open-market trade. The transaction is coded as a grant or award acquisition and reflects deferred compensation, with settlement in cash or stock after the director’s Board retirement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/27/2026 - 06:37 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Buckley Mortimer J

(Last) (First) (Middle)

66 HUDSON BOULEVARD EAST

ATTN: CORPORATE SECRETARY

(Street)

NEW YORK NEW YORK 10001-2192

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PFIZER INC [ PFE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock Units	(1)	04/23/2026		A		7,686.539(2)		(3)	(3)	Common Stock	7,686.539	$26.67	24,391.124	D

Explanation of Responses:

1. Each unit represents one phantom share of common stock.

2. Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors.

3. These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors.

	/s/ Shanice A. Reid, by power of atty., for Mortimer J. Buckley	04/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)